ABSTRACT Leigh's syndrome, which is characterised by progressive neurodegeneration involving the brainstem and basal ganglia, belongs to a family of disorders classified as mitochondrial myopathies. It is most commonly transmitted by an autosomal recessive mode of inheritance, but can sometimes occur in a mitochondrial pattern. It typically presents during infancy with developmental delay and deterioration of brainstem function. Respiratory failure is the common cause of death and postoperative morbidity in patients with Leigh's disease. Herein, we report the case of a 17-year-old female patient with Leigh's syndrome who underwent general anaesthesia for a tracheostomy, which was performed in view of the patient's requirement for long-term ventilation and frequent toileting for secretions. Her respiratory complications included central hypoventilation secondary to brainstem involvement, and obstructive sleep apnoea due to obesity and muscle dystonia. She was hospitalised for acute respiratory decompensation secondary to hospital-acquired pneumonia. We review the anaesthetic implications of this disease and discuss its impact on preoperative, intraoperative and postoperative management.
I NTRO D U C TIO N
Leigh's syndrome, a subacute necrotising encephalomyelopathy, was first described by Dennis Leigh in 1951. (1) It is a 
CA S E R EPO RT
A 17-year-old female patient, who weighed 58 kg, was Within the same month as her current admission, the patient had two prior admissions for unresolved metabolic decompensation secondary to intra-abdominal sepsis. 
The use of ketamine to anaesthetise a patient with Leigh's syndrome for extracorporeal shock wave lithotripsy was first reported in 1997 by Shenkman et al. (10) In that study, the patient's perioperative course was uneventful, with the patient discharged one day after the operation. In 2004, Shear et al also described its use as an adjunct to spinal anaesthesia, without major complications. (4) These studies guided the use of ketamine as an anaesthetic agent in our patient, in whom we were avoiding the use of volatile agents.
The use of long-acting opioids has been avoided due to their potential for respiratory depression, and there is limited experience with regard to newer opioids such as remifentanil.
In a 2004 study by Jacobs et al, (11) the authors reported successful usage of remifentanil for scoliosis surgery in patients with Leigh's syndrome. (11) Remifentanil has a short duration of action and therefore a lower tendency to cause postoperative respiratory depression. In the present case, the decision to use remifentanil was due to its organ-independent elimination and minimal residual side-effects.
The choice of muscle relaxant is another important factor in the intraoperative care of a patient. The use of succinylcholine is associated with a potential risk of rhabdomyolysis and anaesthesia-induced rhabdomyolysis in patients with myopathies. (12) However, the use of intermediate-acting, nondepolarising neuromuscular blocking agents such as atracurium and rocuronium is associated with prolonged recovery from neuromuscular blockade. As such, it is recommended that neuromuscular function be monitored if these neuromuscular blocking agents are used, especially when repeated doses are indicated. In the present case, the patient's airway was secured preoperatively. A minimum of 2 mcg/kg (greater efficiency was achieved with 4 mcg/kg) of remifentanil, infused over 90 s, has been used to establish good intubating conditions. (13) This was a consideration in the event that our patient required reintubation. Muscle dystonia may result in impaired upper airway and lower oesophageal sphincter tone, predisposing the patient to reflux and aspiration. In such cases, the use of rapid sequence intubation and pharmacologic prophylaxis with ranitidine or metoclopramide may be considered when securing the airway. patients with Leigh's syndrome described three patients who developed respiratory failure after general anaesthesia. (15) Although a variety of anaesthetic agents (e.g. halothane and suxamethonium) were used in that study, the same opiate-based premedication (i.e. papaveretum) was used in all patients. The authors of that study concluded that pre-existing respiratory abnormalities (e.g. stridor or irregularity of rhythm) are associated with a significant risk of respiratory failure under general anaesthesia. They also recommend that anaesthesia for routine investigations be avoided under those circumstances. (15) In 2008, Footitt et al (16) 
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